Ling-di Li

发表

MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation‐negative chronic myeloproliferative disorders detected by a newly developed RQ‐PCR based on TaqMan MGB probes

Ya-Zhen Qin, B. Jiang, Yan-rong Liu, 2009, Hematological oncology.

High PRDM16 expression predicts poor outcomes in adult acute myeloid leukemia patients with intermediate cytogenetic risk: a comprehensive cohort study from a single Chinese center

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2020, Leukemia & lymphoma.

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2010, Annals of Hematology.

Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2013, Leukemia research.

Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21)

Ya-Zhen Qin, Yan-rong Liu, Xiao-jun Huang, 2022, Frontiers in Immunology.

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.

Ya-Zhen Qin, B. Jiang, Yan-rong Liu, 2009, Leukemia research.

Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients

Ya-Zhen Qin, Yan-rong Liu, Wen-Min Chen, 2021, Pediatric hematology and oncology.

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2008, Annals of Hematology.

OTT_A_240979 7545..7553

Ya-Zhen Qin, Yan-rong Liu, Wen-Min Chen, 2020 .

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

Yan Liu, Hao Jiang, Q. Jiang, 2008, Acta Haematologica.

High frequency of IKZF1 deletions in Chinese adult patients with acute lymphoblastic leukemia detected by multiplex real-time quantitative PCR

Li-xin Wu, Yan-rong Liu, Xiao-jun Huang, 2017 .

Bortezomib improves progression‐free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma

B. Jiang, Yan-rong Liu, Y. Lai, 2014, Chinese medical journal.

PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy.

Wen-Min Chen, A. Lu, Le-ping Zhang, 2017, Leukemia research.

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

Q. Jiang, B. Jiang, Yan-rong Liu, 2013, Leukemia & lymphoma.

The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2014, Molecular Cancer.

Both Methylation and Copy Number Variation Participated in the Varied Expression of PRAME in Multiple Myeloma

Yan-rong Liu, Wen-Min Chen, Jin Lu, 2020, OncoTargets and therapy.

[The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].

B. Jiang, Yan-rong Liu, G. Ruan, 2013, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia

Hao Jiang, Q. Jiang, Yu Wang, 2023, Leukemia & lymphoma.

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.

Q. Jiang, Yan-rong Liu, G. Ruan, 2011, Leukemia research.

NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2013, Leukemia research.

PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple Myeloma.

Yan-rong Liu, Wen-Min Chen, Jin Lu, 2017, DNA and cell biology.

High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk

Hao Jiang, Q. Jiang, Xiao-jun Huang, 2023, Clinical and experimental medicine.

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2009, Annals of Hematology.

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Hao Jiang, Q. Jiang, B. Jiang, 2014 .

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

R. Gale, Hao Jiang, Q. Jiang, 2015, Leukemia research.

A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms

R. Gale, G. Ruan, Jiao Zhou, 2015, Hematology.

Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with MEF2D fusions

Hao Jiang, Q. Jiang, Yu Wang, 2022, Hematological oncology.

Different kinetic patterns of BCR‐ABL transcript levels in imatinib‐treated chronic myeloid leukemia patients after achieving complete cytogenetic response

Hao Jiang, Xiao-jun Huang, G. Ruan, 2008, International journal of laboratory hematology.

[Detection of common fusion transcript levels in untreated leukemia patients by real-time quantitative RT-PCR technique].

Yan-rong Liu, Xiao-jun Huang, G. Ruan, 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

Q. Jiang, B. Jiang, Yan-rong Liu, 2013, Leukemia & lymphoma.

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

R. Gale, Hao Jiang, Q. Jiang, 2015, Leukemia research.